Chemistry:Felvizumab

From HandWiki

Revision as of 01:46, 6 February 2024 by TextAI2 (talk | contribs) (link)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Short description: Monoclonal antibody

Felvizumab
Monoclonal antibody
Type	Whole antibody
Source	Humanized (from mouse)
Target	RSV
Clinical data
ATC code	none
Identifiers
CAS Number	167747-20-8^Y
ChemSpider	none
UNII	W9ZA2K5Q83
KEGG	D04136^Y
^NY (what is this?) (verify)

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.^[1]^[2]

References

↑ "WHO Drug Information". http://apps.who.int/medicinedocs/index/assoc/s14167e/s14167e.pdf.
↑ "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. 2018. ISBN 978-1-351-78989-9. https://books.google.com/books?id=xUlaDwAAQBAJ&q=Felvizumab&pg=PT1145.

Monoclonal antibodies for infectious disease and toxins

Fungal ("-fung-")

Human ("-fungu-")	Efungumab^†

Viral ("-v(i)[r]-")

Human ("-viru-")	Diridavumab^§ Exbivirumab^§ Foravirumab^§ Libivirumab^§ Rafivirumab^§ Regavirumab^§ Sevirumab^† Suptavumab Tuvirumab^§
Chimeric ("-vixi-")	Cosfroviximab Larcaviximab Porgaviximab
Humanized ("-vizu-")	Felvizumab^§ Lenvervimab^† Motavizumab^† Palivizumab Suvizumab^§

Bacterial ("-ba(c)-")

Human ("-bacu-")	Nebacumab Panobacumab^§ Raxibacumab
Mouse ("-baco-")	Edobacomab^§
Chimeric ("-baxi-")	Pagibaximab^†
Humanized ("-bazu-")	Tefibazumab^†

Toxin ("-tox(a)-")

Human ("-toxu-")	Actoxumab^§ Bezlotoxumab Suvratoxumab
Chimeric ("-toxaxi-")	Obiltoxaximab
Humanized ("-toxazu-")	Urtoxazumab^§

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Felvizumab. Read more

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Felvizumab&oldid=3331055"